|
1
|
Bosch FX, Ribes J, Díaz M and Cléries R:
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 127:S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J, Boix L, Sala M and Llovet J:
Focus on hepatocellular carcinoma. Cancer Cell. 5:215–219. 2004.
View Article : Google Scholar
|
|
3
|
Hollenberg MD and Compton SJ:
International Union of Pharmacology. XXVIII: protease-activated
receptors. Pharmacol Rev. 54:203–219. 2002. View Article : Google Scholar
|
|
4
|
Uusitalo-Jarvinen H, Kurokawa T, Mueller
BM, Andrade-Gordon P, Friedlander M and Ruf W: Role of protease
activated receptor 1 and 2 signaling in hypoxia induced
angiogenesis. arterioscler Thromb Vasc Biol. 27:1456–1462. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kirkland JG, Cottrell GS, Bunnett NW and
Corvera CU: Agonists of protease-activated receptors 1 and 2
stimulate electrolyte secretion from mouse gallbladder. Am J
Physiol Gastrointest Liver Physiol. 293:335–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirahara F, Miyagi Y, Miyagi E, et al:
Trypsinogen expression in human ovarian carcinomas. Int J Cancer.
63:176–181. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawano N, Osawa H, Ito T, et al:
Expression of gelatinase A, tissue inhibitor of
metalloproteinases-2, matrilysin, and trypsin (ogen) in lung
neoplasms: an immunohistochemical study. Hum Pathol. 28:613–622.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyata S, Miyagi Y, Koshikawa N, et al:
Stimulation of cellular growth and adhesion to fibronectin and
vitronectin in culture and tumorigenicity in nude mice by
overexpression of trypsinogen in human gastric cancer cells. Clin
Exp Metastasis. 16:613–622. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Williams SJ, Gotley DC and Antalis TM:
Human trypsinogen in colorectal cancer. Int J Cancer. 93:67–73.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyata S, Koshikawa N, Higashi S, et al:
Expression of trypsin in human cancer cell lines and cancer tissues
and its tight binding tosoluble form of Alzheimer amyloidprecursor
protein in culture. J Biochem. 125:1067–1076. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bernard-Perrone F, Carrere J, Renaud W, et
al: Pancreatic trypsinogen I expression during cell growth and
differentiation of two human colon carcinoma cells. Am J Physiol.
274:G1077–G1086. 1998.PubMed/NCBI
|
|
12
|
Darmoul D, Marie JC, Devaud H, Gratio V
and Laburthe M: Initiation of human colon cancer cell proliferation
by trypsin acting at protease-activated receptor-2. Br J Cancer.
85:772–779. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen KK, Oikonomopoulou K, Li Y and
Hollenberg MD: Proteinases, proteinase-activated receptors (PARs)
and the pathophysiology of cancer and diseases of the
cardiovascular, musculoskeletal, nervous and gastrointestinal
systems. Naunyn Schmiedebergs Arch Pharmacol. 377:377–392. 2008.
View Article : Google Scholar
|
|
14
|
McCubrey JA, Steelman LS, Chappell WH, et
al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant
transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Kempen LC, de Visser KE and Coussens
LM: Inflammation, proteases and cancer. Eur J Cancer. 42:728–734.
2006.PubMed/NCBI
|
|
16
|
Sánchez-Hernández PE, Ramirez-Dueñas MG,
Albarran-Somoza B, García-Iglesias T, del Toro-Arreola A,
Franco-Topete R and Daneri-Navarro A: Protease-activated receptor-2
(PAR-2) in cervical cancer proliferation. Gynecol Oncol. 108:19–26.
2008.PubMed/NCBI
|
|
17
|
Nyberg P, Ylipalosaari M, Sorsa T and Salo
T: Trypsins and their role in carcinoma growth. Exp Cell Res.
312:1219–1228. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kennedy AR, Billings PC, Wan XS and
Newberne PM: Effects of Bowman-Birk Inhibitor on Rat Colon
Carcinogenesis. Nutr Cancer. 43:174–186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vergnolle N: Proteinase-activated
receptors - novel signals for gastrointestinal pathophysiology.
Aliment Pharmacol Ther. 14:257–266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O’Brien PJ, Molino M, Kahn M and Brass LF:
Protease activated receptors: theme and variations. Oncogene.
20:1570–1581. 2001.PubMed/NCBI
|
|
21
|
Masaki T, Shiratori Y, Rengifo W, et al:
Cyclins and cyclin-dependent kinases: comparative study of
hepatocellular carcinoma versus cirrhosis. Hepatology. 37:534–543.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uto H, Ido A, Moriuchi A, et al:
Transduction of antisense cyclin D1using two-step gene transfer
inhibits the growth of rat hepatoma cells. Cancer Res.
61:4779–4783. 2001.PubMed/NCBI
|
|
23
|
Koshikawa N, Hasegawa S, Nagashima Y, et
al: Expression of trypsin by epithelial cells of various tissues,
leukocytes, and neurons in human and mouse. Am J Pathol.
153:937–944. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koshikawa N, Nagashima Y, Miyagi Y,
Mizushima H, Yanoma S, Yasumitsu H and Miyazaki K: Expression of
trypsin in vascular endothelial cells. FEBS Lett. 409:442–448.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyata S, Koshikawa N, Yasumitsu H and
Miyazaki KJ: Trypsin stimulates integrin α(5)β(1)-dependent
adhesion to fibronectin and proliferation of human gastric
carcinoma cells through activation of proteinaseactivated
receptor-2. J Biol Chem. 275:4592–4598. 2000.
|
|
26
|
Hendstrom J, Haglund C, Haapiainen C and
Stenman UH: Serum trypsinogen-2 and trypsin-2-α1-antitrypsin
complex in malignant and benign digestive-tract disease.
Preferential elevation in patients with cholangiocarcinoma. Int J
Cancer. 66:326–331. 1996.
|
|
27
|
Sabri A, Guo J, Elouardighi H, Darrow AL,
Andrade-Gordon P and Steinberg SF: Mechanisms of protease-activated
receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase.
J Biol Chem. 278:11714–11720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Caruso R, Pallone F, Fina D, et al:
Protease-activated receptor-2 activation in gastric cancer cells
promotes epidermal growth factor receptor trans-activation and
proliferation. Am J Pathol. 169:268–278. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ossovskaya VS and Bunnett NW:
Protease-activated receptors: contribution to physiology and
disease. Physiol Rev. 84:579–621. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Whitmarsh AJ and Davis RJ: Transcription
factor AP-1 regulation by mitogen-activated protein kinase signal
transduction pathway. J Mol Med. 74:589–607. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karin M, Liu Z and Zandi E: AP-1 function
and regulation. Curr Opin Biol. 9:240–246. 1997. View Article : Google Scholar
|
|
32
|
Sun Y and Oberley LW: Redox regulation of
transcriptional activators. Free Radic Biol Med. 21:335–348. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu CC and Filipe MI: Update on
proliferation-associated antibodies applicable to formalin-fixed
paraffinembedded tissue and their clinical apprications. Histochem
J. 25:843–853. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Williams GJ, Johnson K, Rudolf J, et al:
Structure of the heterotrimeric PCNA from Sulfolobus
solfataricus. Acta Crystal1ograph Sect F Struct Biol Cryst
Commun. 62:944–948. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sourisseau T, Georgiadis A, Tsapara S, Ali
R, Pestell R, Matter K and Balda MS: Regulation of PCNA and cyclin
D1 expression and epithelial morphogenesis by the ZO-1-regulated
transcription factor ZONAB/DbpA. Mol Cell Biol. 26:2387–2398. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gillardon F, Moll I and Uhlmann E:
Inhibition of c-Fos expression in the UV-irradiated epidermis by
topical application of antisense oligodeoxynucleotides suppresses
activation of proliferating cell nuclear antigen. Carcinogenesis.
16:1853–1856. 1995. View Article : Google Scholar
|
|
37
|
Hirota Y, Osuga Y, Hirata T, et al:
Activation of protease-activated receptor 2 stimulates
proliferation and interleukin (IL)-6 and IL-8 secretion of
endometriotic stromal cells. Hum Reprod. 20:3547–3553. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Macfarlane SR, Sloss CM, Cameron P, Kanke
T, McKenzie RC and Plevin R: The role of intracellular
Ca2+ in the regulation of proteinase-activated
receptor-2 mediated nuclear factor kappa B signalling in
keratinocytes. Br J Pharmacol. 45:535–544. 2005.
|
|
39
|
Baud V and Karin M: Is NF-kappaB a good
target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov.
8:33–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
